Navigation Links
Horizon Therapeutics to Present at UBS Global Life Sciences Conference
Date:9/19/2008

CHICAGO, Sept. 19 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it will present a corporate overview at the UBS Global Life Sciences Conference in New York on Thursday, September 25 at 1:30 p.m. ET at the Grand Hyatt Hotel.

About Horizon Therapeutics

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit http://www.horizontherapeutics.com.


'/>"/>
SOURCE Horizon Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
2. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
3. BioHorizons Announces the Purchase of Implant Logic Systems
4. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
5. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
6. BioHorizons Announces Agreement to Purchase Implant Logic Systems
7. Out beyond the horizon
8. Out beyond the horizon
9. Synvista Therapeutics Posts Letter to Stockholders on Web Site
10. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... for SmartBiome -- a novel metagenomic deep-sequencing research platform. SmartBiome combines the ... of hundreds of different genes. The selective early access program is open ...
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... for the fourth quarter and fiscal year ended September 30, 2016. ... , , ... -based life sciences and diagnostics company that develops and commercializes proprietary ... Highlights Achieved revenues of $1.4 million more than ...
(Date:12/6/2016)... ... 2016 , ... Discovering new clues to natural treatments that could allow our ... our brains. And searching for keys to our immune systems by studying parasite-resistant fish. ... 2017 Edith and Peter O’Donnell Awards by The Academy of Medicine, ...
(Date:12/6/2016)... ... December 06, 2016 , ... Clinical ... it has acquired the assets of Theorem Clinical Research - Clinical Supplies ... clinical trial drug packaging, labeling, storage, reconciliation, and distribution for pharmaceutical trials ...
Breaking Biology Technology:
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
(Date:11/14/2016)... CLARA, Calif. , Nov. 14, 2016 ... the biometric identification market, Frost & Sullivan ... Frost & Sullivan Award for Visionary Innovation ... player in the biometric identification market by ... multi-modal verification solution for instant, seamless, and ...
Breaking Biology News(10 mins):